- Home
- VOR vs NREF Comparison
VOR vs NREF Comparison
Compare VOR & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- NREF
- Stock Information
- Founded
- VOR 2015
- NREF 2019
- Country
- VOR United States
- NREF United States
- Employees
- VOR N/A
- NREF N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- NREF Real Estate Investment Trusts
- Sector
- VOR Health Care
- NREF Real Estate
- Exchange
- VOR Nasdaq
- NREF Nasdaq
- Market Cap
- VOR 207.1M
- NREF 233.4M
- IPO Year
- VOR 2021
- NREF 2020
- Fundamental
- Price
- VOR $18.94
- NREF $13.39
- Analyst Decision
- VOR Buy
- NREF Hold
- Analyst Count
- VOR 6
- NREF 3
- Target Price
- VOR $84.00
- NREF $14.75
- AVG Volume (30 Days)
- VOR 392.4K
- NREF 54.9K
- Earning Date
- VOR 11-07-2025
- NREF 10-30-2025
- Dividend Yield
- VOR N/A
- NREF 14.95%
- EPS Growth
- VOR N/A
- NREF 142.14
- EPS
- VOR N/A
- NREF 3.20
- Revenue
- VOR N/A
- NREF $149,435,000.00
- Revenue This Year
- VOR N/A
- NREF $27.88
- Revenue Next Year
- VOR N/A
- NREF $5.41
- P/E Ratio
- VOR N/A
- NREF $4.18
- Revenue Growth
- VOR N/A
- NREF 104.25
- 52 Week Low
- VOR $2.62
- NREF $12.14
- 52 Week High
- VOR $65.80
- NREF $18.09
- Technical
- Relative Strength Index (RSI)
- VOR 34.54
- NREF 45.74
- Support Level
- VOR $19.62
- NREF $12.36
- Resistance Level
- VOR $26.76
- NREF $13.50
- Average True Range (ATR)
- VOR 2.09
- NREF 0.38
- MACD
- VOR -1.28
- NREF 0.02
- Stochastic Oscillator
- VOR 9.23
- NREF 75.36
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. The company provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.